rs202032281

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_001267550.2(TTN):​c.37202-4T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 11 hom., cov: 18)
Exomes 𝑓: 0.014 ( 87 hom. )
Failed GnomAD Quality Control

Consequence

TTN
NM_001267550.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00009880
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -7.49

Publications

4 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 2-178661846-A-G is Benign according to our data. Variant chr2-178661846-A-G is described in ClinVar as Benign. ClinVar VariationId is 220772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.37202-4T>C splice_region_variant, intron_variant Intron 179 of 362 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.37202-4T>C splice_region_variant, intron_variant Intron 179 of 362 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.0182
AC:
2643
AN:
145286
Hom.:
10
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.00430
Gnomad AMI
AF:
0.0213
Gnomad AMR
AF:
0.0185
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.0782
Gnomad SAS
AF:
0.0315
Gnomad FIN
AF:
0.0349
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.0186
Gnomad OTH
AF:
0.0175
GnomAD2 exomes
AF:
0.0240
AC:
5629
AN:
234670
AF XY:
0.0237
show subpopulations
Gnomad AFR exome
AF:
0.00410
Gnomad AMR exome
AF:
0.0237
Gnomad ASJ exome
AF:
0.0120
Gnomad EAS exome
AF:
0.0753
Gnomad FIN exome
AF:
0.0309
Gnomad NFE exome
AF:
0.0190
Gnomad OTH exome
AF:
0.0241
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0143
AC:
20336
AN:
1423610
Hom.:
87
Cov.:
31
AF XY:
0.0148
AC XY:
10489
AN XY:
708734
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00275
AC:
89
AN:
32414
American (AMR)
AF:
0.0204
AC:
875
AN:
42834
Ashkenazi Jewish (ASJ)
AF:
0.00901
AC:
230
AN:
25532
East Asian (EAS)
AF:
0.0598
AC:
2232
AN:
37304
South Asian (SAS)
AF:
0.0256
AC:
2172
AN:
84988
European-Finnish (FIN)
AF:
0.0292
AC:
1490
AN:
50986
Middle Eastern (MID)
AF:
0.0110
AC:
50
AN:
4546
European-Non Finnish (NFE)
AF:
0.0113
AC:
12270
AN:
1086306
Other (OTH)
AF:
0.0158
AC:
928
AN:
58700
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.296
Heterozygous variant carriers
0
2051
4102
6154
8205
10256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0182
AC:
2642
AN:
145378
Hom.:
11
Cov.:
18
AF XY:
0.0190
AC XY:
1346
AN XY:
70740
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00429
AC:
165
AN:
38482
American (AMR)
AF:
0.0185
AC:
272
AN:
14736
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
50
AN:
3396
East Asian (EAS)
AF:
0.0783
AC:
374
AN:
4778
South Asian (SAS)
AF:
0.0315
AC:
143
AN:
4538
European-Finnish (FIN)
AF:
0.0349
AC:
348
AN:
9970
Middle Eastern (MID)
AF:
0.00345
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
0.0186
AC:
1235
AN:
66276
Other (OTH)
AF:
0.0173
AC:
35
AN:
2020
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.337
Heterozygous variant carriers
0
146
292
437
583
729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0181
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 18, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early-onset myopathy with fatal cardiomyopathy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tibial muscular dystrophy Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myopathy, myofibrillar, 9, with early respiratory failure Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
2.8
DANN
Benign
0.81
PhyloP100
-7.5
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000099
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202032281; hg19: chr2-179526573; COSMIC: COSV59977990; COSMIC: COSV59977990; API